株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

女性性機能障害:世界の治験動向

Female Sexual Dysfunction Global Clinical Trials Review, H2, 2017

発行 GlobalData 商品コード 348425
出版日 ページ情報 英文 156 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.80円で換算しております。
Back to Top
女性性機能障害:世界の治験動向 Female Sexual Dysfunction Global Clinical Trials Review, H2, 2017
出版日: 2017年08月17日 ページ情報: 英文 156 Pages
概要

当レポートでは、女性性機能障害関連の治験に関する最新動向について分析しており、主要国における治験件数、治験の段階別進行状況、被験者採用の状況、有望なスポンサー、企業や研究機関における研究の進行状況、有望な薬剤の比較などの情報を提供しています。

当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要5カ国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:女性医療の治験における女性性機能障害の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:女性医療の治験における女性性機能障害の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

女性性機能障害治療薬の治験に携わっている主要企業

有望な薬剤

最新の治験ニュース

治験プロファイルの概要

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC4473CTIDB

GlobalData's clinical trial report, "Female Sexual Dysfunction Global Clinical Trials Review, H2, 2017" provides an overview of Female Sexual Dysfunction clinical trials scenario. This report provides top line data relating to the clinical trials on Female Sexual Dysfunction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Top Countries Contributing to Clinical Trials in Central and South America 15
  • Clinical Trials by G7 Countries: Proportion of Female Sexual Dysfunction to Women's Health Clinical Trials 16
  • Clinical Trials by Phase in G7 Countries 17
  • Clinical Trials in G7 Countries by Trial Status 18
  • Clinical Trials by E7 Countries: Proportion of Female Sexual Dysfunction to Women's Health Clinical Trials 19
  • Clinical Trials by Phase in E7 Countries 20
  • Clinical Trials in E7 Countries by Trial Status 21
  • Clinical Trials by Phase 22
  • In Progress Trials by Phase 23
  • Clinical Trials by Trial Status 24
  • Clinical Trials by End Point Status 25
  • Subjects Recruited Over a Period of Time 26
  • Clinical Trials by Sponsor Type 27
  • Prominent Sponsors 28
  • Top Companies Participating in Female Sexual Dysfunction Therapeutics Clinical Trials 30
  • Prominent Drugs 32
  • Clinical Trial Profile Snapshots 33

Appendix 154

  • Abbreviations 154
  • Definitions 154
  • Research Methodology 155
  • Secondary Research 155
  • About GlobalData 156
  • Contact Us 156
  • Source 156

List of Tables

List of Tables

  • Female Sexual Dysfunction Therapeutics, Global, Clinical Trials by Region, 2017* 7
  • Female Sexual Dysfunction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Female Sexual Dysfunction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Female Sexual Dysfunction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
  • Female Sexual Dysfunction Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
  • Female Sexual Dysfunction Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
  • Female Sexual Dysfunction Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 14
  • Female Sexual Dysfunction Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 15
  • Proportion of Female Sexual Dysfunction to Women's Health Clinical Trials, G7 Countries (%), 2017* 16
  • Female Sexual Dysfunction Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Female Sexual Dysfunction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Proportion of Female Sexual Dysfunction to Women's Health Clinical Trials, E7 Countries (%), 2017* 19
  • Female Sexual Dysfunction Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
  • Female Sexual Dysfunction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Female Sexual Dysfunction Therapeutics, Global, Clinical Trials by Phase, 2017* 22
  • Female Sexual Dysfunction Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 23
  • Female Sexual Dysfunction Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
  • Female Sexual Dysfunction Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Female Sexual Dysfunction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Female Sexual Dysfunction Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27
  • Female Sexual Dysfunction Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29
  • Female Sexual Dysfunction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 31
  • Female Sexual Dysfunction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 32

List of Figures

List of Figures

  • Female Sexual Dysfunction Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
  • Female Sexual Dysfunction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Female Sexual Dysfunction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Female Sexual Dysfunction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
  • Female Sexual Dysfunction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
  • Female Sexual Dysfunction Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
  • Female Sexual Dysfunction Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 14
  • Female Sexual Dysfunction Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 15
  • Proportion of Female Sexual Dysfunction to Women's Health Clinical Trials, G7 Countries (%), 2017* 16
  • Female Sexual Dysfunction Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Female Sexual Dysfunction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Proportion of Female Sexual Dysfunction to Women's Health Clinical Trials, E7 Countries (%), 2017* 19
  • Female Sexual Dysfunction Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
  • Female Sexual Dysfunction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Female Sexual Dysfunction Therapeutics, Global, Clinical Trials by Phase (%), 2017* 22
  • Female Sexual Dysfunction Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 23
  • Female Sexual Dysfunction Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
  • Female Sexual Dysfunction Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Female Sexual Dysfunction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Female Sexual Dysfunction Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 27
  • Female Sexual Dysfunction Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
  • Female Sexual Dysfunction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 30
  • Female Sexual Dysfunction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 32
  • GlobalData Methodology 155
Back to Top